EBF1 is a tumor-promoting TF in triple-negative breast cancer (24), whereas SNAI1/2 are master regulatory TFs for organogenesis and wound healing in normal tissue as well as for the epithelial–mesenchymal transition (EMT) in cancer cells (25). This evidence concerns the gene SNAI1 and triple-negative breast carcinoma.